<?xml version='1.0' encoding='utf-8'?>
<?xml-stylesheet type="text/xsl" href="/v2/static/oai2.xsl"?>
<OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2026-10-11T18:32:50Z</responseDate>
  <request identifier="oai:figshare.com:article/34037751" metadataPrefix="oai_dc" verb="GetRecord">https://api.figshare.com/v2/oai</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:figshare.com:article/34037751</identifier>
        <datestamp>2026-10-01T02:04:44Z</datestamp>
        <setSpec>category_1</setSpec>
        <setSpec>category_4</setSpec>
        <setSpec>category_19</setSpec>
        <setSpec>category_873</setSpec>
        <setSpec>category_734</setSpec>
        <setSpec>category_931</setSpec>
        <setSpec>category_64</setSpec>
        <setSpec>portal_63</setSpec>
        <setSpec>item_type_6</setSpec>
        <setSpec>month_year_10_2026</setSpec>
      </header>
      <metadata>
        <oai_dc:dc xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"  xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
          <dc:title>Benchmarking Affinity-Based
Docking for Irreversible
Acetylcholinesterase Inhibitors: A Physics-Informed Reactivity Framework
for Stereoselective Potency Prioritization</dc:title>
          <dc:creator>Jeongyun Kim (452920)</dc:creator>
          <dc:creator>Jin Yoo (1501492)</dc:creator>
          <dc:creator>Doo-Hee Lee (8457927)</dc:creator>
          <dc:creator>Ku Kang (10959330)</dc:creator>
          <dc:subject>Biophysics</dc:subject>
          <dc:subject>Biochemistry</dc:subject>
          <dc:subject>Pharmacology</dc:subject>
          <dc:subject>Chemical Sciences not elsewhere classified</dc:subject>
          <dc:subject>Biological Sciences not elsewhere classified</dc:subject>
          <dc:subject>Information Systems not elsewhere classified</dc:subject>
          <dc:subject>Cancer</dc:subject>
          <dc:subject>tpsa alone correlates</dc:subject>
          <dc:subject>small panel (&lt;</dc:subject>
          <dc:subject>single docked pose</dc:subject>
          <dc:subject>permutation support (&lt;</dc:subject>
          <dc:subject>informed reactivity framework</dc:subject>
          <dc:subject>gnina cnn scores</dc:subject>
          <dc:subject>activated serine alkoxide</dc:subject>
          <dc:subject>autodock vina affinity</dc:subject>
          <dc:subject>irreversible acetylcholinesterase inhibitors</dc:subject>
          <dc:subject>bounded prioritization tool</dc:subject>
          <dc:subject>reactive geometry rather</dc:subject>
          <dc:subject>p &lt;/ sub</dc:subject>
          <dc:subject>bounded rather</dc:subject>
          <dc:subject>affinity scores</dc:subject>
          <dc:subject>p &lt;/</dc:subject>
          <dc:subject>resulting framework</dc:subject>
          <dc:subject>reactive complex</dc:subject>
          <dc:subject>p –</dc:subject>
          <dc:subject>computational prioritization</dc:subject>
          <dc:subject>catalytic serine</dc:subject>
          <dc:subject>&gt;&lt; sub</dc:subject>
          <dc:subject>poses rather</dc:subject>
          <dc:subject>benchmarking affinity</dc:subject>
          <dc:subject>r &lt;/</dc:subject>
          <dc:subject>n &lt;/</dc:subject>
          <dc:subject>test preserves</dc:subject>
          <dc:subject>stereochemical results</dc:subject>
          <dc:subject>selecting covalent</dc:subject>
          <dc:subject>reproducible signal</dc:subject>
          <dc:subject>ranked poses</dc:subject>
          <dc:subject>pesticide classes</dc:subject>
          <dc:subject>often based</dc:subject>
          <dc:subject>noncovalent docking</dc:subject>
          <dc:subject>mechanistic interpretation</dc:subject>
          <dc:subject>measured human</dc:subject>
          <dc:subject>kinetic measurement</dc:subject>
          <dc:subject>group chemistry</dc:subject>
          <dc:subject>downhill within</dc:subject>
          <dc:subject>discriminating information</dc:subject>
          <dc:subject>descriptor correlations</dc:subject>
          <dc:subject>curated set</dc:subject>
          <dc:subject>covalent phosphylation</dc:subject>
          <dc:subject>bond formation</dc:subject>
          <dc:subject>based docking</dc:subject>
          <dc:subject>62 ),</dc:subject>
          <dc:subject>11 ),</dc:subject>
          <dc:description>Irreversible organophosphorus inhibitors of acetylcholinesterase
(AChE) act by covalent phosphylation of the catalytic serine, yet
their computational prioritization is often based on affinity scores
from noncovalent docking. We benchmark that assumption against a curated
set of measured human-AChE inhibition rate constants (&lt;i&gt;n&lt;/i&gt; = 14; G-, V-, and organophosphate-pesticide classes, including a
configuration-resolved VX pair). AutoDock Vina affinity (Spearman
ρ = +0.12) and GNINA CNN scores (ρ = −0.40) do
not provide statistically reliable potency rankings; explicit covalent
docking also remains weak (ρ = +0.23, &lt;i&gt;n&lt;/i&gt; = 11),
with bootstrap confidence intervals crossing zero. Selecting covalent-compatible
(near-attack) poses rather than top-ranked poses does not change this
outcome. A quantum-chemical cluster scan supports a mechanistic interpretation:
once the activated serine alkoxide/reactive complex is formed, P–O
bond formation is downhill within the model, so the discriminating
information is expected to reside in electrophilicity, leaving-group
chemistry, and transport into reactive geometry rather than in a single
docked pose. Consistently, mechanism-oriented molecular descriptors
recover a modest but reproducible signal: TPSA alone correlates with
potency (ρ = −0.62), and a Gaussian-process model used
primarily for calibrated uncertainty yields leave-one-out ρ
= +0.55 with permutation support (&lt;i&gt;p&lt;/i&gt; ≈ 0.01)
and a bootstrap CI whose lower bound lies near zero. A leave-both-VX-enantiomers-out
test preserves the experimental &lt;i&gt;S&lt;/i&gt;&lt;sub&gt;P&lt;/sub&gt; &gt; &lt;i&gt;R&lt;/i&gt;&lt;sub&gt;P&lt;/sub&gt; ordering. Given the small panel (&lt;i&gt;n&lt;/i&gt; = 14), the descriptor correlations and stereochemical results are
reported as exploratory and uncertainty-bounded rather than predictive.
The resulting framework is presented as an uncertainty-bounded prioritization
tool for data-scarce covalent AChE inhibitors, not as a substitute
for kinetic measurement.</dc:description>
          <dc:date>2026-09-30T00:00:00Z</dc:date>
          <dc:type>Text</dc:type>
          <dc:type>Journal contribution</dc:type>
          <dc:identifier>10.1021/acsomega.6c08355.s001</dc:identifier>
          <dc:relation>https://figshare.com/articles/journal_contribution/Benchmarking_Affinity-Based_Docking_for_Irreversible_Acetylcholinesterase_Inhibitors_A_Physics-Informed_Reactivity_Framework_for_Stereoselective_Potency_Prioritization/34037751</dc:relation>
          <dc:rights>CC BY-NC 4.0</dc:rights>
        </oai_dc:dc>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
